Search results
Results from the WOW.Com Content Network
Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. [3] CVDs constitute a class of diseases that includes: coronary artery diseases (e.g. angina, heart attack), heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease ...
By 2050, 22% of the US will be over the age of 65, whereas seniors made up just 13% of the population 10 years ago, studies say. The median age in the US is projected to increase from 37 in 2010 ...
A large proportion of adults in the United States – nearly 1 in 3 – may have one of two forms of iron deficiency, even if they don’t have a health condition for which they would be screened ...
Nearly 90% of adults over age 20 in the U.S. are at risk of developing heart disease, ... 800-290-4726 more ways to reach us. ... “It is alarming that 90% of the population is at least stage 1 ...
Coronary artery disease (CAD), also called coronary heart disease (CHD), ischemic heart disease (IHD), [13] myocardial ischemia, [14] or simply heart disease, involves the reduction of blood flow to the cardiac muscle due to build-up of atherosclerotic plaque in the arteries of the heart. [5][6][15] It is the most common of the cardiovascular ...
This first table gives a convenient overview of the general categories and broad causes. The leading cause is cardiovascular disease at 31.59% of all deaths. Rate of death by cause. Percent of all deaths. Category. Cause. Percent. Percent. I. Communicable, maternal, neonatal, and nutritional disorders.
t. e. Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. [11] High blood pressure usually does not cause symptoms itself. [1] It is, however, a major risk factor for stroke, coronary artery disease, heart failure, atrial fibrillation, peripheral ...
The trial included more than 17,600 adults ages 45 and up with heart disease who got either a weekly 2.4-milligram dose of semaglutide, which is the drug used in Wegovy, or a placebo.About three ...